Navitas Life Sciences named as a ‘Top 10 Innovator - Pharma and Life Sciences Solution Providers 2022’ by Medhealth Outlook
Friday, 11 November 2022

Navitas Life Sciences today announced that it has been named as a Top 10 Innovator – Pharma and Life Sciences Solution Providers 2022 by Medhealth Outlook.

Continue Reading
H.I.G. Capital completes recapitalization of Navitas Life Sciences
Tuesday, 13 September 2022

H.I.G. Capital ("H.I.G."), a leading global alternative investment firm with over $50 billion of equity capital under management, is pleased to

Continue Reading
Everest Group has named Navitas Life Sciences as a Major Contender in its report Clinical Development Platforms Products PEAK Matrix® Assessment 2022
Thursday, 14 July 2022

Navitas Life Sciences, a provider of Clinical, Pharmacovigilance, and Regulatory solutions, today announced that it has been named a ‘Major Contender’ in the Everest Group’s Clinical Development Platforms Products PEAK Matrix® Assessment 2022.

Continue Reading
Navitas Life Sciences has been named as a Major Contender in Everest Group’s Life Sciences Operations PEAK Matrix® Assessment 2022
Thursday, 23 June 2022

Navitas Life Sciences, a provider of Pharmacovigilance, Regulatory, and Clinical solutions, today announced that it has been named as a ‘Major Contender’ in the Everest Group’s Life Sciences Operations PEAK Matrix® Assessment 2022.

Continue Reading
Navitas Data Sciences' Shrishaila Patil named as the new PHUSE India Single Day Event lead for 2022
Monday, 10 January 2022

10 January, 2022 Navitas Data Sciences, the global Functional Service Provider (FSP) division of Navitas Life Sciences, are delighted that Shrishaila Patil our Vice President of Statistical Programming,

Continue Reading
Navitas Life Sciences and UL Announce Partnership to Advance Operational Efficiency and Regulatory Compliance in the Life Sciences Industry
Monday, 03 January 2022

Navitas Life Sciences, a technology-backed global Clinical Research Organization (CRO) and UL, the global safety science leader,

Continue Reading
Navitas Life Sciences has been named as a Top 10 Pharma and Life Sciences Tech Solution Provider 2021 by Industry Tech Outlook
Wednesday, 20 October 2021

Navitas Life Sciences, a wholly owned subsidiary of TAKE Solutions and provider of Pharmacovigilance, Regulatory, and Clinical solutions

Continue Reading
Navitas Life Sciences’ innovative Regulatory Technology, pharmaREADY®, achieves 200 active customers
Wednesday, 08 September 2021

Navitas Life Sciences, a TAKE Solutions company, announces that it has achieved its 200th customer win for its innovative Regulatory Technology,

Continue Reading
Navitas Life Sciences has been named as a Major Contender in Everest Group’s Pharmacovigilance and Complaint Management Operations - Services PEAK Matrix Assessment 2021
Thursday, 15 April 2021

Navitas Life Sciences, a wholly owned subsidiary of TAKE Solutions and provider of Pharmacovigilance, Regulatory, and Clinical solutions and services today announced

Continue Reading
Navitas Life Sciences Provides Improved Clinical Trial Oversight and Actionable Insights Enabled by OneClinical™ Analytics, Powered by ThoughtSphere
Monday, 24 June 2019

ThoughtSphere, a fast growing, cloud-based clinical data hub and analytics SaaS company, today announced that Navitas Life Sciences, a full service CRO....

Continue Reading
Page 1 of 6